Nah, I don't think so. Pharmaceutical companies that have 8 FDA approved, drugs, generating CFP, 2 more products pending approval now, partnerships with the third largest generic drug company in the world as well as epic, HITK, Novel, TPN, etc....
24 drugs in the pipeline...
3 partnerships on NDAs etc...
Do not trade at a 27m market cap.
Besides their ~10% of Novel is likely worth more then their curent market cap currently is.
Market Data 
Markets 
AI
